(2019)
p. 350 - 351
(2021/06/07)p. 2023 - 2031
(2021/02/26)p. 224 - 229
(2020/02/15)p. 3077 - 3090
(2018/03/08)p. 11895 - 11902
(2017/09/07)p. 47297 - 47308
(2017/10/19)p. 15651 - 15655
(2017/12/02)p. 4750 - 4754
(2017/11/29)(2016/04/26)
p. 226 - 237
(2016/02/05)(2016/06/14)
(2015/02/18)
p. 394 - 405
(2014/10/15)p. 2535 - 2538
(2014/03/21)(2013/04/25)
p. 865 - 873
(2012/10/29)p. 1331 - 1334
(2012/07/13)p. 177 - 180
(2011/03/22)(2011/02/15)
(2009/05/28)
p. 2297 - 2303
(2009/12/01)p. 479 - 484
(2010/06/21)p. 4467 - 4469
(2009/12/01)p. 3995 - 4005
(2009/05/26)p. 1369 - 1372
(2009/12/04)(2008/06/13)
p. 951 - 953
(2007/10/03)(2008/06/13)
p. 2998 - 2999
(2007/10/03)p. 2448 - 2449
(2007/10/03)p. 261 - 273
(2007/10/03)p. 1489 - 1494
(2007/10/03)p. 168 - 173
(2007/10/02)morpholine
ethyl iodoacetae
4-(benzoyloxy)morpholine
ethyl acetate
carbon monoxide
1,1-bis-(4-chloro-phenyl)-2-morpholin-4-yl-ethanol
2-(4-morpholinyl)acetylhydrazine
2-morpholino-N-phenylacetamide
ethyl trans-3-(3-nitrophenyl)oxirane-2-carboxylate
N-(5-(5-(1H-pyrazol-1-yl)-1H-benzo[d]imidazol-1-yl)-2',4'-difluoro-[1,1'-biphenyl]-3-yl)-2-morpholinoacetamide